Report Detail

Pharma & Healthcare Global (United States, European Union and China) Nausea Medicine Market Research Report 2019-2025

  • RnM3651046
  • |
  • 06 August, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Nausea is an unpleasant, diffuse sensation of unease and discomfort, often perceived as an urge to vomit. While not painful, it can be a debilitating symptom if prolonged, and has been described as placing discomfort on the chest, upper abdomen, or back of the throat.
Many pharmacologic medications are available for the treatment of nausea. There is no medication that is clearly superior to other medications for all cases of nausea. The choice of antiemetic medication may be based on the situation during which the person experiences nausea. For people with motion sickness and vertigo, antihistamines and anticholinergics such as meclizine and scopolamine are particularly effective. Nausea and vomiting associated with migraine headaches respond best to dopamine antagonists such as metoclopramide, prochlorperazine, and chlorpromazine. In cases of gastroenteritis, serotonin antagonists such as ondansetron were found to suppress nausea and vomiting, as well as reduce the need for IV fluid resuscitation.
In 2019, the market size of Nausea Medicine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nausea Medicine.

This report studies the global market size of Nausea Medicine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nausea Medicine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Merck
Sanofi
TESARO
Roche
Pfizer
GlaxoSmithKline
ANI Pharmaceuticals
...

Market Segment by Product Type
Antacids
Antagonists
Anti-Anxiety Drugs
Steroids
Cannabinoids

Market Segment by Application
Hospital
Clinics
Pharmaceutical Companies

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Nausea Medicine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nausea Medicine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Nausea Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Nausea Medicine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Antacids
      • 1.3.3 Antagonists
      • 1.3.4 Anti-Anxiety Drugs
      • 1.3.5 Steroids
      • 1.3.6 Cannabinoids
    • 1.4 Market Segment by Application
      • 1.4.1 Global Nausea Medicine Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinics
      • 1.4.4 Pharmaceutical Companies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Nausea Medicine Market Size
      • 2.1.1 Global Nausea Medicine Revenue 2014-2025
      • 2.1.2 Global Nausea Medicine Sales 2014-2025
    • 2.2 Nausea Medicine Growth Rate by Regions
      • 2.2.1 Global Nausea Medicine Sales by Regions 2014-2019
      • 2.2.2 Global Nausea Medicine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Nausea Medicine Sales by Manufacturers
      • 3.1.1 Nausea Medicine Sales by Manufacturers 2014-2019
      • 3.1.2 Nausea Medicine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Nausea Medicine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nausea Medicine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Nausea Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Nausea Medicine Price by Manufacturers
    • 3.4 Key Manufacturers Nausea Medicine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Nausea Medicine Market
    • 3.6 Key Manufacturers Nausea Medicine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Antacids Sales and Revenue (2014-2019)
      • 4.1.2 Antagonists Sales and Revenue (2014-2019)
      • 4.1.3 Anti-Anxiety Drugs Sales and Revenue (2014-2019)
      • 4.1.4 Steroids Sales and Revenue (2014-2019)
      • 4.1.5 Cannabinoids Sales and Revenue (2014-2019)
    • 4.2 Global Nausea Medicine Sales Market Share by Type
    • 4.3 Global Nausea Medicine Revenue Market Share by Type
    • 4.4 Nausea Medicine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Nausea Medicine Sales by Application

    6 United States

    • 6.1 United States Nausea Medicine Breakdown Data by Company
    • 6.2 United States Nausea Medicine Breakdown Data by Type
    • 6.3 United States Nausea Medicine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Nausea Medicine Breakdown Data by Company
    • 7.2 European Union Nausea Medicine Breakdown Data by Type
    • 7.3 European Union Nausea Medicine Breakdown Data by Application

    8 China

    • 8.1 China Nausea Medicine Breakdown Data by Company
    • 8.2 China Nausea Medicine Breakdown Data by Type
    • 8.3 China Nausea Medicine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Nausea Medicine Breakdown Data by Company
    • 9.2 Rest of World Nausea Medicine Breakdown Data by Type
    • 9.3 Rest of World Nausea Medicine Breakdown Data by Application
    • 9.4 Rest of World Nausea Medicine Breakdown Data by Countries
      • 9.4.1 Rest of World Nausea Medicine Sales by Countries
      • 9.4.2 Rest of World Nausea Medicine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck
      • 10.1.1 Merck Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Nausea Medicine
      • 10.1.4 Nausea Medicine Product Introduction
      • 10.1.5 Merck Recent Development
    • 10.2 Sanofi
      • 10.2.1 Sanofi Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Nausea Medicine
      • 10.2.4 Nausea Medicine Product Introduction
      • 10.2.5 Sanofi Recent Development
    • 10.3 TESARO
      • 10.3.1 TESARO Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Nausea Medicine
      • 10.3.4 Nausea Medicine Product Introduction
      • 10.3.5 TESARO Recent Development
    • 10.4 Roche
      • 10.4.1 Roche Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Nausea Medicine
      • 10.4.4 Nausea Medicine Product Introduction
      • 10.4.5 Roche Recent Development
    • 10.5 Pfizer
      • 10.5.1 Pfizer Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Nausea Medicine
      • 10.5.4 Nausea Medicine Product Introduction
      • 10.5.5 Pfizer Recent Development
    • 10.6 GlaxoSmithKline
      • 10.6.1 GlaxoSmithKline Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Nausea Medicine
      • 10.6.4 Nausea Medicine Product Introduction
      • 10.6.5 GlaxoSmithKline Recent Development
    • 10.7 ANI Pharmaceuticals
      • 10.7.1 ANI Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Nausea Medicine
      • 10.7.4 Nausea Medicine Product Introduction
      • 10.7.5 ANI Pharmaceuticals Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Nausea Medicine Sales Channels
      • 11.2.2 Nausea Medicine Distributors
    • 11.3 Nausea Medicine Customers

    12 Market Forecast

    • 12.1 Global Nausea Medicine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Nausea Medicine Sales Forecast by Type
    • 12.3 Global Nausea Medicine Sales Forecast by Application
    • 12.4 Nausea Medicine Forecast by Regions
      • 12.4.1 Global Nausea Medicine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Nausea Medicine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Nausea Medicine. Industry analysis & Market Report on Nausea Medicine is a syndicated market report, published as Global (United States, European Union and China) Nausea Medicine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Nausea Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,587.92
      3,881.88
      5,175.84
      3,017.60
      4,526.40
      6,035.20
      508,957.60
      763,436.40
      1,017,915.20
      273,880.00
      410,820.00
      547,760.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report